News
NBTX
3.290
+0.22%
0.007
Nanobiotix Updates Voting Rights and Share Capital as of March 2025
TipRanks · 5d ago
Nanobiotix Reports Managerial Stock Transactions in April 2025
TipRanks · 5d ago
Voting Rights and Shares Capital of the Company
Barchart · 5d ago
Weekly Report: what happened at NBTX last week (0407-0411)?
Weekly Report · 6d ago
Nanobiotix Discloses Managerial Share Acquisitions in April 2025
TipRanks · 04/10 10:47
Weekly Report: what happened at NBTX last week (0331-0404)?
Weekly Report · 04/07 09:22
Guggenheim Maintains Buy on Nanobiotix, Lowers Price Target to $8
Benzinga · 04/04 14:34
Nanobiotix price target lowered to $8 from $12 at Guggenheim
TipRanks · 04/04 11:11
Nanobiotix’s Promising Future: Buy Rating Backed by Data-Rich 2025 and Strategic Advancements
TipRanks · 04/04 10:16
Nanobiotix (NBTX) Gets a Hold from UBS
TipRanks · 04/04 08:47
Nanobiotix SA ADR Reports 2024 Financial Results
TipRanks · 04/04 03:55
Nanobiotix: Strategic Partnerships and Clinical Advancements Drive Buy Rating
TipRanks · 04/03 08:45
Nanobiotix Reports 2024 Progress and Financial Results
TipRanks · 04/02 20:47
Nanobiotix GAAP EPS of -€1.44
Seeking Alpha · 04/02 20:23
NANOBIOTIX SA - CASH RUNWAY EXTENDED INTO MID-2026
Reuters · 04/02 20:15
NANOBIOTIX Provides Business Update and Reports Full Year 2024 Financial Results
Barchart · 04/02 15:15
Earnings Scheduled For April 2, 2025
Benzinga · 04/02 08:32
Analysts Have Conflicting Sentiments on These Healthcare Companies: Pfizer (PFE), Nanobiotix (NBTX) and PTC Therapeutics (PTCT)
TipRanks · 04/02 07:40
Nanobiotix to Announce 2024 Financial Results and Host Conference Call
TipRanks · 03/31 12:28
Positive Clinical Data and Strategic Partnerships Drive Buy Rating for Nanobiotix
TipRanks · 03/31 10:16
More
Webull provides a variety of real-time NBTX stock news. You can receive the latest news about Nanobiotix S.A. through multiple platforms. This information may help you make smarter investment decisions.
About NBTX
Nanobiotix SA is a France-based nanomedicine company. The Company designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. It develops new tools for cancer that utilize a physical mode of action at the cellular level of the cancer cell. The Company's NanoXray technology comprises three products. Local treatment (surgery and radiotherapy) provides potential cure and gives the systemic treatment a better chance to life expectancy. NanoXray products are developed for the efficacy of radiotherapy in the tumor cell. Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo.